Preserve-Transplant Study
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 240 participants.
Also called NCT03102996
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 240 participants
- Sponsor
- Registry
-
NCT03102996
-
- Other papers using this trial's data
- Sodium bicarbonate for kidney transplant recipients with metabolic acidosis in Switzerland: a multicentre, randomised, single-blind, placebo-controlled, phase 3 trial
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Switzerland
- Registry status
- Completed
Technical summary
Registry record NCT03102996. Randomized; single masking; primary purpose treatment. Start 2017-06-12 (actual); primary completion 2021-06-29 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Preserve-Transplant Study
- Condition
- Acidosis
- Condition
- Renal Insufficiency
- Condition
- Kidney Transplantation
- Intervention (Drug)
- Nephrotrans
- Intervention (Other)
- Placebo
- Lead sponsor
- University of Zurich
Record details
- Record id
cardio:ct-nct03102996- Content hash
2550f4d75004d8cd79a1a2c70456d92f87ea24a6ee180cbd397bd00eea9721d8